Ready for a rapid, radical reboot of the global innovation system for a truly free and open 21st century knowledge economy?
The Open Science Summit is an attempt to gather all stakeholders who want to liberate our scientific and technological commons and enable a new era of decentralized, distributed innovation to solve humanity's greatest challenges.
Misha Angrist is Assistant Professor of the Practice at the Duke University Institute for Genome Sciences & Policy. He holds a PhD degree in Genetics from Case Western Reserve University, an MFA in Writing and Literature from the Bennington Writing Seminars, and was formerly a board-eligible genetic counselor. He has covered the biotechnology industry as market-research analyst and worked as an independent life sciences consultant, writer and editor.
In April 2007 he became the fourth subject in Harvard geneticist George Church's Personal Genome Project and in 2009 had his full genome sequenced at Duke. His book, Here is a Human Being: At the Dawn of Personal Genomics, will be published in the fall by Harper Collins.
Rochelle Cooper Dreyfuss is the Pauline Newman Professor of Law at New York University School of Law and the Director of the Engelberg Center on Innovation Law and Policy. She holds B.A. and M.S. degrees in Chemistry and spent several years as a research chemist before entering Columbia University School of Law, where she served as Articles and Book Review Editor of the Law Review. After graduating, she was a law clerk to Chief Judge Wilfred Feinberg of the U.S. Court of Appeals for the Second Circuit and to Chief Justice Warren Burger of the U.S. Supreme Court. She is a member of the American Law Institute and served as a Reporter for its Project on Intellectual Property: Principles Governing Jurisdiction, Choice of Law, and Judgments in Transnational Disputes. She also sits on the National Academy of Science's Committee on Science, Technology and Law, Secretary of the Department of Health & Human Service's Advisory Committee on Genetics, Health, and Society, and BNA's Advisory Board to USPQ.
Professor Dreyfuss was a consultant to the Federal Courts Study Committee, to the Presidential Commission on Catastrophic Nuclear Accidents, and to the Federal Trade Commission. She served on the National Academy of Sciences' Committees on Intellectual Property in Genomic and Protein Research and Innovation and on Intellectual Property Rights in the Knowledge-Based Economy. She is a past chair of the Intellectual Property Committee of the American Association of Law Schools. She has visited at The University of Chicago Law School, University of Washington School of Law, and Santa Clara University Law School. In addition to articles in her specialty areas, she has co-authored casebooks on civil procedure and intellectual property law.
David R. Koepsell earned his PhD in Philosophy as well as his Law degree from the University of Buffalo where he studied with Barry Smith (ontologist). He has authored numerous articles as well as authored and edited several books, including Searle on the Institutions of Social Reality, co-edited with Laurence Moss, (Oxford UK: Blackwell 2003), Reboot World, (New York: Writer's Club Press 2003) (fiction), and The Ontology of Cyberspace: Law, Philosophy, and the Future of Intellectual Property, which has been translated into Japanese and Portuguese. He has lectured worldwide on issues ranging from civil rights, philosophy, science, ontology, intellectual property theory, society, and religion.
Koepsell has practiced law, worked for Bowstreet, Inc. as an ontologist in Portsmouth, New Hampshire, and taught at SUNY Buffalo. He was appointed Asst. Prof. of Philosophy at TU Delft beginning in September 2008. He is an associate editor of Free Inquiry magazine. He is the co-founder, with Edward Summer, of Carefully Considered Productions, an educational media not-for-profit corporation.
Dr. Luigi Palombi is an international expert in gene patents. He is an accomplished patent lawyer who has represented many organizations around the world that have sought to challenge the validity of gene patents.
He is also an academic at the Centre for the Governance of Knowledge and Development at The Australian National University.